Cargando…
Bleeding events and maintenance dose of prasugrel: BLESS pilot study
OBJECTIVE: To evaluate changes in residual platelet reactivity (RPR) over time, and bleeding and ischaemic events rate using 5 vs 10 mg maintenance dose (MD) regimens of prasugrel 1 month after acute coronary syndrome (ACS). BACKGROUND: The optimal level of RPR with prasugrel may change over time af...
Autores principales: | Carrabba, Nazario, Parodi, Guido, Marcucci, Rossella, Valenti, Renato, Gori, Anna Maria, Migliorini, Angela, Comito, Vincenzo, Bellandi, Benedetta, Abbate, Rosanna, Gensini, Gian Franco, Antoniucci, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5093371/ https://www.ncbi.nlm.nih.gov/pubmed/27843564 http://dx.doi.org/10.1136/openhrt-2016-000460 |
Ejemplares similares
-
Safety of immediate reversal of anticoagulation by protamine to reduce bleeding complications after infarct artery stenting for acute myocardial infarction and adjunctive abciximab therapy
por: Parodi, Guido, et al.
Publicado: (2010) -
Comparison of lower loading dose of prasugrel with conventional loading dose of prasugrel in Indian patients undergoing percutaneous coronary interventions
por: Kumari, Priti, et al.
Publicado: (2018) -
Real-world comparison of clopidogrel, prasugrel and ticagrelor in patients undergoing primary percutaneous coronary intervention
por: Krishnamurthy, Arvindra, et al.
Publicado: (2019) -
The effect of bivalirudin and closure device on bleeding outcomes after percutaneous coronary interventions
por: Dobies, David R, et al.
Publicado: (2014) -
Validity of a PCI Bleeding Risk Score in patient subsets stratified for body mass index
por: Dobies, David R, et al.
Publicado: (2015)